Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Pediatr Cardiol ; 2024 May 27.
Article in English | MEDLINE | ID: mdl-38802599

ABSTRACT

The population of adults with congenital heart disease (ACHD) is constantly growing. There seems to be a consensus that these patients are difficult to manage especially if compared to patients with acquired heart disease. The aim of this study is to compare outcomes and results of cardiac surgery in ACHD patients with a reference population of adults with acquired cardiac disease. Retrospective study of 5053 consecutive patients older than 18 years hospitalized for cardiac surgery during a 5-years period in our Institution. Two groups of patients were identified. Group I: 419 patients operated for congenital heart disease; Group II: 4634 patients operated for acquired heart disease. In each Group were identified low, medium, and high-risk patients, according to validated scores. Right ventricular outflow tract surgery was the most frequent procedure in Group I, while coronary artery by-pass grafting was the most common in Group II. Patients with ACHD were younger (37.8 vs. 67.7 years), with higher number of previous operations (32.1% vs. 6.9%), had longer post-ICU hospital stay (11 vs. 8 days) but had lower ICU stay (1 vs. 2 days), shorter assisted mechanical ventilation (12 vs. 14 h) and lower surgical mortality (1 vs. 3.7%) (all p < 0.001). No differences were found in term of post-operative complications (12.4 vs. 15%). The surgical treatment of ACHD patients can be done with excellent results and if compared with acquired cardiac disease patients they have better results with shorter ICU stay and lower mortality.

2.
J Cardiovasc Med (Hagerstown) ; 25(1): 76-87, 2024 01 01.
Article in English | MEDLINE | ID: mdl-38079284

ABSTRACT

AIMS: Congenital heart diseases (CHDs) often show a complex 3D anatomy that must be well understood to assess the pathophysiological consequences and to guide therapy. Three-dimensional imaging technologies have the potential to enhance the physician's comprehension of such spatially complex anatomies. Unfortunately, due to the new introduction in clinical practice, there is no evidence on the current applications. We conducted a survey to examine how 3D technologies are currently used among CHD European centres. METHODS: Data were collected using an online self-administered survey via SurveyMonkey. The questionnaire was sent via e-mail and the responses were collected between January and June 2022. RESULTS: Ninety-eight centres correctly completed the survey. Of these, 22 regularly perform 3D rotational angiography, 43 have the availability to print in-silico models, and 22 have the possibility to visualize holographic imaging/virtual reality. The costs were mostly covered by the hospital or the department of financial resources. CONCLUSION: From our survey, it emerges that these technologies are quite spread across Europe, despite not being part of a routine practice. In addition, there are still not enough data supporting the improvement of clinical management for CHD patients. For this reason, further studies are needed to develop clinical recommendations for the use of 3D imaging technologies in medical practice.


Subject(s)
Heart Defects, Congenital , Humans , Heart Defects, Congenital/diagnostic imaging , Imaging, Three-Dimensional , Surveys and Questionnaires , Printing, Three-Dimensional , Models, Anatomic
3.
PLoS One ; 18(12): e0295332, 2023.
Article in English | MEDLINE | ID: mdl-38100399

ABSTRACT

In meta-analysis literature, there are several checklists describing the procedures necessary to evaluate studies from a qualitative point of view, whereas preliminary quantitative and statistical investigations on the "combinability" of trials have been neglected. Covariate balance is an important prerequisite to conduct meta-analysis. We propose a method to identify unbalanced trials with respect to a set of covariates, in presence of covariate imbalance, namely when the randomized controlled trials generate a meta-sample that cannot satisfy the requisite of randomization/combinability in meta-analysis. The method is able to identify the unbalanced trials, through four stages aimed at achieving combinability. The studies responsible for the imbalance are identified, and then they can be eliminated. The proposed procedure is simple and relies on the combined Anderson-Darling test applied to the Empirical Cumulative Distribution Functions of both experimental and control meta-arms. To illustrate the method in practice, two datasets from well-known meta-analyses in the literature are used.


Subject(s)
Research Design , Clinical Protocols , Computer Simulation
4.
Stat Methods Appt ; : 1-35, 2022 Oct 24.
Article in English | MEDLINE | ID: mdl-36311813

ABSTRACT

Students' and graduates' mobility is an interesting topic of discussion especially for the Italian education system and universities. The main reasons for migration and for the so called brain drain, can be found in the socio-economic context and in the famous North-South divide. Measuring mobility and understanding its dynamic over time and space are not trivial tasks. Most of the studies in the related literature focus on the determinants of such phenomenon, in this paper, instead, combining tools coming from graph theory and Topological Data Analysis we propose a new measure for the attitude to mobility. Each mobility trajectory is represented by a graph and the importance of the features constituting the graph are evaluated over time using persistence diagrams. The attitude to mobility of the students is then ranked computing the distance between the individual persistence diagram and the theoretical persistence diagram of the stayer student. The new approach is used for evaluating the mobility of the students that in 2008 enrolled in an Italian university. The relation between attitude to mobility and the main socio-demographic variables is investigated.

5.
Catheter Cardiovasc Interv ; 89(6): 1045-1050, 2017 May.
Article in English | MEDLINE | ID: mdl-27862909

ABSTRACT

OBJECTIVES: This study aimed to report a large, single-center experience of percutaneous arterial duct (AD) closure using Amplatzer Duct Occluder II Additional Sizes device (ADO II-AS)(St. Jude Medical Corp, St. Paul, MN, USA). BACKGROUND: Transcatheter closure of AD remains challenging in low body weight patients and those who have a persisting shunt following a previous attempt at interventional closure. Recent technical advances in device design may address these issues. METHODS: From May 2011 to April 2016, 109 patients underwent attempted percutaneous closure of AD with ADO II-AS at our Institution. Mean age and weight were 4.8 ± 8.1 years (range 0-48) and 21.4 ± 20.6 kg (range 3-93), respectively. Fifteen patients (13.8%) were ≤6 kg (age 3.5 ± 2.0 months; weight 4.7 ± 1.1 kg). Arterial duct morphology was type A in 62 (57%), type B in 1 (1%), type C in 32 (29%), type D in 7 (6%) and type E in 6 patients (6%), respectively. Arterial approach was used to negotiate and deploy the occluding device in 103 patients (94.5%). RESULTS: AD diameter was 2.2 ± 0.6 (range 1.5-4.5) resulting in QP/QS of 1.9 ± 0.7 (range 1-3.3). Mean pulmonary artery pressure and PA/aortic pressure ratio were 19.3 ± 5.0 mm Hg (range 12-38) and 0.34 ± 0.14 (range 0.14-0.95), respectively. Successful device deployment was achieved in 107 patients (98.2%). Neither procedural morbidity nor mortality was recorded. Immediate, 24h and mid-term (30 ± 17 months) complete occlusion was recorded in 71%, 98.1%, and 100% of patients, respectively. CONCLUSION: In our experience, trans-catheter closure of AD of different sizes and morphologies using ADO II-AS is highly feasible, safe and effective also in challenging anatomic/clinical settings. © 2016 Wiley Periodicals, Inc.


Subject(s)
Cardiac Catheterization/instrumentation , Ductus Arteriosus, Patent/therapy , Septal Occluder Device , Adolescent , Adult , Aortography , Cardiac Catheterization/adverse effects , Child , Child, Preschool , Ductus Arteriosus, Patent/diagnostic imaging , Ductus Arteriosus, Patent/physiopathology , Female , Humans , Infant , Infant, Newborn , Italy , Male , Middle Aged , Prosthesis Design , Time Factors , Treatment Outcome , Young Adult
6.
Percept Mot Skills ; 123(3): 792-809, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27609627

ABSTRACT

The aim of this study was to identify the independent and interactive effects of possession strategy, pitch location, and game period on the offensive actions performed by the winning teams in the 2012 European Football Championship. The non-clinical magnitude-based inferences method was used to interpret the true effect of the performance indicators on the response variable. The offensive team possessions were grouped into winning (n = 2035) and losing (n = 2071). The winning teams performed offensive processes mainly using the possession play strategy (OR: 0.75, very likely negative effect of the direct play). When the analysis included the pitch location, negative interaction effect was found for the direct play, which ended up in the central path (OR: 0.70, very likely negative effect). On the contrary, the direct play in the second half of the match seemed to produce an effect on the probability of the winning teams performing offensive processes (OR: 1.59, most likely positive effect). The results of multivariate analyses showed that the offensive team possession profiles required a careful investigation because the possession strategy changed under the conjoint effect of pitch location and game period.


Subject(s)
Athletic Performance/statistics & numerical data , Competitive Behavior , Cooperative Behavior , Group Processes , Soccer/statistics & numerical data , Adult , Europe , Humans , Male
7.
J Cardiovasc Echogr ; 24(1): 25-28, 2014.
Article in English | MEDLINE | ID: mdl-28465900

ABSTRACT

We investigated the left ventricular (LV) function, using for the first time strain (S) and strain rate (SR) imaging, in long-term survivors affected by acute lymphoblastic leukemia treated with a low cumulative dose of anthracyclines, and in presence of a normal global LV systolic and diastolic function. A total of 21 were enrolled in the study. The mean cumulative dose of anthracylines was 180 mg/m2 (range: 120-210 mg/m2). As control group 21 age-sex matched healthy subjects were included. Radial S (17 ± 3% vs. 55 ± 6%, P < 0.0001) and SR (2.1 ± 0.3 vs. 3.0 ± 0.8 1\s, P < 0.0001), assessed on the midsegment of the posterior wall from the parasternal views were significantly reduced when compared with controls. Conversely, myocardial performance index was not able to discriminate between patients and controls. In this preliminary study, the myocardial deformation indices appear to be a more sensitive noninvasive technique for detecting subclinical LV dysfunction than other echocardiographic measurements.

8.
Pediatr Cardiol ; 34(7): 1645-51, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23591799

ABSTRACT

Percutaneous closure currently is widely considered to be the first-choice therapeutic option in the treatment of ostium secundum atrial septal defect (ASD). The Amplatzer Septal Occluder (ASO) device is the most used prosthesis, although its influence on cardiac function still is under active investigation. This study aimed to evaluate the impact of the ASO device size on left ventricular (LV) function in pediatric patients using the speckle-tracking strain imaging technology. The study enrolled 43 nonobese pediatric patients submitted to percutaneous ASD closure with the Amplatzer Septal Occluder device and grouped them according to the size of the occluding prosthesis into three groups: a small-device group (≤ 10 mm, group 1), a medium-size-device group (11-16 mm, group 2), and a large-device group (≥ 17 mm, group 3). Echocardiographic data were compared among the groups and with the data of an age-, weight-, and gender-matched control group (50 patients). The large-device group showed a significant impairment in the strain rate value of the basal LV segments. In particular, the mean basal circumferential and radial strain rate values were lower than either normal or the values of the small- and medium-device groups. However, only the absolute device diameter reached statistical significance in the multivariate analysis. The large Amplatzer Septal Occluding device significantly impaired LV systolic function, particularly that of juxtaprosthetic segments, as shown in the strain rate analysis.


Subject(s)
Heart Atria/diagnostic imaging , Heart Septal Defects, Atrial/surgery , Ventricular Function, Left , Cardiac Catheterization , Child , Echocardiography, Transesophageal , Female , Follow-Up Studies , Heart Septal Defects, Atrial/diagnostic imaging , Heart Septal Defects, Atrial/physiopathology , Humans , Male , Septal Occluder Device , Time Factors , Treatment Outcome
9.
Stat Med ; 30(22): 2671-82, 2011 Sep 30.
Article in English | MEDLINE | ID: mdl-21786283

ABSTRACT

The main goal of meta-analysis is to combine data across studies or data sets to obtain summary estimates. In this paper, the novelty is to propose a statistical tool to assess a possible covariate imbalance in baseline variables to investigate similarity of trials. We conducted the detection of the covariate imbalance, first, through some graphical comparison of the empirical cumulative distribution functions or ECDFs, which are built by putting together arms or trials according to some risk factor, and second, through some non-parametric tests such as the Kolmogorov-Smirnov and the Anderson-Darling tests. To overcome the huge presence of ties, we conducted the statistical tests on perturbed versions of the original data sets. The applications concern two real meta-analyses of RCTs: the first one, on interferon-alpha treatment of chronic hepatitis C, with 107 studies involved, and the second one, on cholesterol-lowering treatment with statins, with 14 studies involved. The applications allow for analysis of both when risk factors reflecting demographic or clinical differences in experimental and control arms are balanced or not and when there are structural differences between the levels of some study variables, in order to proceed eventually with the pooling of the studies. We developed our suggestion, which is a quantitative way to assess combinability in meta-analysis, only with respect to RCTs, but it could be applied to a minor extent to non-RCTs.


Subject(s)
Data Interpretation, Statistical , Meta-Analysis as Topic , Randomized Controlled Trials as Topic , Female , Hepatitis C, Chronic/drug therapy , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Hypercholesterolemia/drug therapy , Interferon-alpha/therapeutic use , Male
10.
Neuroepidemiology ; 36(3): 169-76, 2011.
Article in English | MEDLINE | ID: mdl-21546778

ABSTRACT

BACKGROUND: The global burden of neurodegenerative diseases is increasing. Previous studies reported differences related to age, gender and socioeconomic status. We calculated the cognitive performances of a Sicilian population aged 65 years or older, by means of a door-to-door population-based survey in Bagheria city, Sicily. METHODS: A door-to-door survey was carried out in the city of Bagheria, Sicily (prevalence day September 30, 2006). A cohort of 2,200 persons was randomly stratified, obtaining a 25% sample of the whole population. Cognitive function was assessed by Mini Mental State Examination (MMSE). Percentile distributions by age, gender, education and working activity were calculated. Regression models were used to analyze the relationship between the investigated variables and cognitive performance. RESULTS: A total of 1,837 persons agreed to participate (1,062 women and 775 men). Distribution of MMSE showed a highly significant inverse linear trend related to the increasing age (p < 0.0001) and to the degree of education (p < 0.0001), both in men and women. We observed a significant association between higher education and a better cognitive performance (OR 6.91; CI 3.24-14.76) and an inverse association between manual kind of occupation versus not manual and a poorer cognitive status (OR 0.82; CI 0.67-0.997). Height was associated with decreased cognitive performances in women (OR = 1.03; CI = 1.01-1.05) but not in men (OR = 0.997; CI = 0.993-1.002). CONCLUSIONS: These findings provide a feature of cognitive performances in Sicily, measured by MMSE scores in individuals aged 65 years or older.


Subject(s)
Cognition Disorders/diagnosis , Cognition Disorders/epidemiology , Population Surveillance/methods , Residence Characteristics , Age Factors , Aged , Aged, 80 and over , Cognition/physiology , Cohort Studies , Female , Humans , Male , Mental Status Schedule , Sicily/epidemiology
11.
J Clin Gastroenterol ; 44(10): 702-6, 2010.
Article in English | MEDLINE | ID: mdl-20485187

ABSTRACT

BACKGROUND: Acute uncomplicated diverticulitis (AUD) may show histologic and serologic signs of inflammation. GOALS: To assess whether serologic markers of inflammation may be predictive of abnormal histology in AUD. STUDY: Twenty-one consecutive patients affected by AUD were studied (15 Males, 6 Females, mean age 66.19 y, range 43 to 85 y). Diagnosis of AUD was based on specific endoscopic and CT scan patterns. Several serologic markers were assessed [White blood cells (WBC), Erytro-sedimentation Rate, C-reactive protein (CRP), fibrinogen, α1-acid glycoprotein]. Neutrophilic and lymphocytic inflammatory infiltrate was also scored. RESULTS: WBC was increased in 4/21 pts (19.4%), Erytro-sedimentation Rate in 12/21 pts (57.14%), CRP in 13/21 pts (61.9%), fibrinogen in 5/21 pts (23.8%), and α1-acid glycoprotein in 6/21 pts (28.57%). All serologic markers were related with the degree of histologic damage. In patients scoring 3 in neutrophilic infiltrate (severe active inflammation), all markers showed a statistical significant relation (ranging from P=0.004 for WBC to P=0.00001 for fibrinogen). CRP was the most sensitive marker of mild-moderate histologic damage, as it was increased in 4/10 (40%) patients scoring 0 or 1 in neutrophilic infiltrate (absence of mild active inflammation) (P=0.005). CONCLUSIONS: Serologic markers showed a strict relation with the degree of histologic damage in AUD. Moreover, CRP is the most sensitive marker of mild-moderate histologic damage.


Subject(s)
Colon/immunology , Colon/pathology , Diverticulitis, Colonic/diagnosis , Inflammation Mediators/blood , Acute Disease , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Blood Sedimentation , C-Reactive Protein/analysis , Colonoscopy , Diverticulitis, Colonic/blood , Diverticulitis, Colonic/immunology , Diverticulitis, Colonic/pathology , Female , Fibrinogen/analysis , Humans , Italy , Leukocyte Count , Lymphocytes/immunology , Male , Middle Aged , Neutrophil Infiltration , Orosomucoid/analysis , Predictive Value of Tests , Prospective Studies , Sensitivity and Specificity , Severity of Illness Index , Tomography, X-Ray Computed
12.
Int J Colorectal Dis ; 24(1): 49-55, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18941760

ABSTRACT

BACKGROUND AND AIMS: Information about faecal calprotectin (FC) in colonic diverticular disease (DD) are lacking. We assessed FC in colonic DD, comparing it with irritable bowel syndrome (IBS) patients and healthy controls. Moreover, we compared FC levels in different degrees of DD and assessed FC in symptomatic DD before and after treatment. MATERIALS AND METHODS: Forty-eight consecutive patients with a new endoscopic diagnosis of DD (16 with asymptomatic diverticulosis, 16 with symptomatic uncomplicated DD, 16 with acute uncomplicated diverticulitis), 16 healthy controls, and 16 IBS patients were studied. FC was assessed by semi-quantitative method and compared with histological inflammation. Moreover, FC was reassessed in symptomatic DD after 8 weeks of treatment. RESULTS/FINDINGS: FC was not increased in healthy controls and IBS patients. No difference was found between asymptomatic diverticulosis, healthy controls, and IBS patients (p = n.s.). We found higher FC values in acute uncomplicated diverticulitis (p < 0.0005) and in symptomatic uncomplicated DD (p < 0.005) than in healthy controls and in IBS patients. FC values correlated with inflammatory infiltrate (p < 0.0005). FC decreased after treatment to normal values both in acute uncomplicated diverticulitis (p < 0.0005) and in symptomatic uncomplicated DD (p < 0.005) after treatment. INTERPRETATIONS/CONCLUSIONS: FC may be useful to detect colonic inflammation in DD and in distinguishing symptomatic DD from IBS, as well as in assessing response to therapy in DD.


Subject(s)
Diverticulosis, Colonic/metabolism , Feces/chemistry , Leukocyte L1 Antigen Complex/metabolism , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Case-Control Studies , Colonoscopy , Diverticulosis, Colonic/drug therapy , Female , Gastrointestinal Agents/therapeutic use , Humans , Irritable Bowel Syndrome/metabolism , Lymphocytes/metabolism , Male , Mesalamine/therapeutic use , Middle Aged , Neutrophils/metabolism , Rifamycins/therapeutic use , Rifaximin , Severity of Illness Index
13.
Dig Dis Sci ; 54(10): 2175-82, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19058000

ABSTRACT

We assessed the onset of malignant and nonmalignant complications in a cohort of celiac disease (CD) patients under gluten-free diet (GFD). Five hundred and forty-nine CD patients were retrospectively assessed. Two hundred and fifty-one (45.7%) showed classical, 262 (47.7%) subclinical, and 36 (6.6%) silent form of CD at the time of the diagnosis. The mean time under GFD was 7.13 years (range 1-15 years). Out of 549 patients, 381 (69.4%) were fully compliant, 112/549 (20.4%) reported less than one dietary transgression/month, and 56/549 (10.2%) reported at least one dietary transgression/month. Out of 549 patients, 18 (3.3%) patients developed complications under GFD (seven malignant and 11 nonmalignant complications). Fourteen patients were previously affected by classical CD (5.6% of the overall patients with classical CD), and four were affected by subclinical CD (1.5% of the overall patients with subclinical CD). None of the patients affected by silent CD developed complications. There was no statistical difference between the mean age of the two groups developing complications (P = n.s.). Complications appeared after a mean time under GFD of 6.5 years in classical CD, and after a mean time of 3.5 years in subclinical CD (P = n.s.). Finally, 6/14 (42.8%) patients with classical CD were not fully compliant to GFD, while 2/4 (50%) of subclinical CD patients were not fully compliant to GFD (P = n.s.). Less than 5% of CD patients may develop complications under GFD. Complications seem to affect more classical CD than subclinical CD, and seem to be irrespective of optimal GFD adherence.


Subject(s)
Celiac Disease/complications , Diet, Gluten-Free , Celiac Disease/diet therapy , Humans , Patient Compliance , Retrospective Studies , Time Factors
14.
J Clin Gastroenterol ; 42(6): 699-703, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18347509

ABSTRACT

GOAL: The aim of this study was to assess and grade the mucosal inflammatory infiltrate in different degrees of diverticular disease (DD) and to compare them with healthy matched controls. BACKGROUND: Mucosal inflammation in colonic DD has never been investigated. In particular, it is unknown whether inflammation may be found in every degree of DD. MATERIALS AND METHODS: Thirty consecutive patients with a new endoscopic diagnosis of DD (10 with asymptomatic diverticulosis, 10 with symptomatic uncomplicated DD, and 10 with acute uncomplicated diverticulitis) and 10 healthy controls were studied. RESULTS: A neutrophilic inflammatory infiltrate was found only in acute uncomplicated diverticulitis (overall score, 26). The mean lymphocytic cell density was significantly higher in symptomatic DD (median lymphocytic density, 7) and acute uncomplicated diverticulitis (median lymphocytic density, 11). Subdividing the patients according to different degrees of DD, we found higher lymphocytic cell density even in asymptomatic diverticulosis (median lymphocytic density, 6.5) than healthy controls (median lymphocytic density, 4; P<0.02). CONCLUSIONS: We found an increased inflammatory infiltrate in DD according to the degree of the disease and higher than healthy controls. Moreover, also asymptomatic diverticulosis shows higher inflammatory cell density than controls.


Subject(s)
Diverticulitis, Colonic/diagnosis , Diverticulosis, Colonic/diagnosis , Inflammation/pathology , Intestinal Mucosa/pathology , Aged , Case-Control Studies , Cell Count , Colonoscopy , Diverticulitis, Colonic/classification , Diverticulitis, Colonic/pathology , Diverticulosis, Colonic/classification , Diverticulosis, Colonic/pathology , Female , Humans , Inflammation/etiology , Lymphocytes/metabolism , Male , Middle Aged , Neutrophil Infiltration , Severity of Illness Index
15.
Dig Dis Sci ; 53(9): 2474-9, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18231855

ABSTRACT

PURPOSE: There is no consensus about the correct definition of uncomplicated diverticulitis (UD) in clinical practice. We evaluated therefore whether clinical picture of UD differs from complicated diverticulitis (CD). Fifty consecutive eligible patients (21 males, 29 females, mean age 63.6 years, range 47-75 years) were studied. Symptoms, the inflammatory indices, and Computerized Tomography (CT) scan of the abdomen were assessed at the time of admission. RESULTS: Thirty-nine patients classified were affected by UD and 11 patients by CD. CD patients showed more severe clinical picture than UD and required urgent Hospital admission. Conversely, most of the patients affected by UD were treated as outpatients. CD patients showed higher symptom scores than UD patients, except the parameter "diarrhea". All CD patients showed increases in all inflammatory indices. Conversely, all UD patients showed increased ESR, CRP and fibrinogen, but WBC and alpha1-acid glycoprotein were increased in only a few cases. CT scan in CD patients always showed signs of severe colonic and pericolonic inflammation. Conversely, UD patients often showed moderate localized signs of inflammation without complication. CONCLUSIONS: Clinical, laboratory, and radiological findings may easily differentiate uncomplicated from complicated diverticulitis of the colon. This integrated approach may be helpful in clinical settings.


Subject(s)
Colon/diagnostic imaging , Colon/metabolism , Diverticulitis, Colonic/classification , Diverticulitis, Colonic/complications , Aged , Blood Sedimentation , C-Reactive Protein/metabolism , Colon/physiopathology , Diagnosis, Differential , Diverticulitis, Colonic/diagnostic imaging , Diverticulitis, Colonic/metabolism , Female , Fibrinogen/metabolism , Humans , Male , Middle Aged , Tomography, X-Ray Computed
16.
Mov Disord ; 22(15): 2263-7, 2007 Nov 15.
Article in English | MEDLINE | ID: mdl-17853482

ABSTRACT

Aim of this study was to investigate the relationship between height in young adult age and Parkinson's disease (PD) risk. We included 266 persons affected by idiopathic PD. Patients were matched by age and sex to 266 controls by a random selection from the municipality of residence. We collected information about height preceding PD from official documents where these characteristics referred to young adult age (nearly 30 years). We compared height in cases and controls by calculating differences in mean distribution and by chi(2) analyses. Crude and adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated by logistic regression models. Mean height was significantly lower in persons affected by PD compared to controls (P = 0.03). Difference was significant only in men (P = 0.001). Logistic regression models showed an inverse association between height and PD (OR 0.35; CI 0.16, 0.79; P < 0.01 comparing individuals in the highest percentiles of height with those in the lowest). Our results indicate an association between height and PD in men. Considering that dopamine sensitivity in the hypothalamic-pituitary axis is related to adult height, our findings suggest a relationship between PD and factors modulating somatic growth early in life.


Subject(s)
Body Height , Parkinson Disease/epidemiology , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Humans , Logistic Models , Male , Middle Aged , Odds Ratio , Predictive Value of Tests , Risk Factors
17.
Med Sci Monit ; 13(4): CR187-90, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17392649

ABSTRACT

BACKGROUND: Up to 35% of H. pylori-positive patients remain infected after a first eradication attempt. Lactoferrin, a natural anti-bacterial glycoprotein, seems a promising tool in treating H. pylori infection, but it has never been used in second-line treatment. MATERIAL/METHODS: A prospective, randomized study was conducted on 70 consecutive patients with persistent H. pylori infection after failure of the first standard treatment schedule. All patients were randomly treated with ranitidine bismuth citrate (RBC, 400 mg b.d.), esomeprazole (40 mg/day), amoxycillin (1 g t.d), and tinidazole (500 mg b.d.) without (group A) or with (group B) supplementation of bovine lactoferrin (200 mg b.d). One month after conclusion of therapy, endoscopy was performed in those patients for whom the examination was clinically relevant. The remaining patients were checked by 13C-urea breath test. RESULTS: Sixty-seven patients were fully compliant and completed the study (33, i.e. 94.28%, in group A and 34, 97.14%, in group B). One group A patient (2.85%) was excluded for protocol violation and one group B patient (2.85%) was lost to follow-up. H. pylori eradication was obtained in 31/33 (on intention-to-treat: 88.57%, 95%CI: 87-99%) group A patients and in 33/34 (on intention-to-treat: 94.28%, 95%CI: 86-100%) group B patients (p=ns). 16/68 patients (23.53%) experienced side effects (29.41% in group A and 17.64% in group B, p= 0.05). CONCLUSIONS: Lactoferrin supplementation was found effective in reducing side-effect incidence. Moreover, it seems capable of achieving a slight (and not statistically significant) improvement in eradicating H. pylori when used in second-line treatment.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Helicobacter Infections/drug therapy , Helicobacter pylori , Lactoferrin/therapeutic use , Adult , Aged , Amoxicillin/therapeutic use , Anti-Bacterial Agents/adverse effects , Bismuth/therapeutic use , Breath Tests , Endoscopy, Gastrointestinal , Esomeprazole/therapeutic use , Female , Humans , Lactoferrin/adverse effects , Male , Middle Aged , Prospective Studies , Ranitidine/analogs & derivatives , Ranitidine/therapeutic use , Tinidazole/therapeutic use
18.
Int J Colorectal Dis ; 22(9): 1103-8, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17390144

ABSTRACT

BACKGROUND AND AIMS: The role of probiotics in the treatment of diverticulitis is still not known. The aim of our study was to investigate whether balsalazide and/or VSL#3 is effective in preventing diverticulitis recurrence. MATERIALS AND METHODS: In this pilot study, 30 consecutive patients (19 males, 11 females, mean age 60.1 years, range 47-75 years) affected by uncomplicated diverticulitis of the colon were monitored. After obtaining remission, the patients were randomly assigned to one of the following groups as follows: group A, balsalazide 2.25 g daily for 10 days every month plus VSL#3 450 billions/day for 15 days every month and group B, VSL#3 alone 450 billions/day for 15 days every month. Primary end-point was considered the maintaining of remission throughout a 12-month follow-up. Secondary end-points considered were (1) the assessment of the overall scores at the end of the follow-up and (2) the effects of the two different treatments with regards to every symptom assessed. RESULTS/FINDINGS: One group A patient was withdrawn from the study at the 6th month and one group B patient was lost at the 6th month of follow-up. One group A patient (6.66%) showed relapse of symptoms at the 10th month of follow-up. At the end of follow-up, 11 patients were completely symptom-free (73.33%), whilst 2 patients complained of only mild, recurrent symptoms (13%). Two group B patients (13.33%) showed relapse of the disease at the 5th and 8th month of follow-up, respectively. At the end of follow-up, 8 patients were completely symptom-free (60%), 2 patients complained of mild, recurrent symptoms (13.33%), 1 patient (6.66%) complained of mild but continuous symptoms. No side effects were recorded throughout the follow-up in both groups. INTERPRETATION/CONCLUSIONS: Combination probiotic/anti-inflammatory drug was found better than probiotic treatment in preventing relapse of uncomplicated diverticulitis of the colon, even if without statistical significance.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Diverticulitis, Colonic/drug therapy , Gastrointestinal Agents/therapeutic use , Lacticaseibacillus casei/physiology , Mesalamine/therapeutic use , Phenylhydrazines/therapeutic use , Probiotics/chemistry , Probiotics/therapeutic use , Acute Disease , Adult , Aged , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Bifidobacterium/metabolism , Bifidobacterium/physiology , Drug Therapy, Combination , Female , Follow-Up Studies , Gastrointestinal Agents/adverse effects , Humans , Lacticaseibacillus casei/metabolism , Male , Mesalamine/adverse effects , Middle Aged , Phenylhydrazines/adverse effects , Pilot Projects , Recurrence , Treatment Outcome
19.
Med Sci Monit ; 12(6): PI29-32, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16733496

ABSTRACT

BACKGROUND: Budesonide is a steroid with low systemic effect and high effectiveness in the treatment of Crohn's Disease (CD). Beclomethasone dipropionate (BDP) is also a steroid with the same systemic effects, but it has been never investigated in CD. MATERIAL/METHODS: To evaluate the effectiveness and tolerability of BDP versus budesonide in treating CD, we enrolled 30 consecutive patients affected by mild-to-moderate non-fistulizing, non-obstructive Crohn's disease (CDAI < or = 250) (13 M and 17 F, mean age: 33.4 years, range: 16-71 years) in whom this diagnosis was made for the first time. The patients were randomly treated for 8 weeks with budesonide 9 mg/day (group A, 15 patients) or with BDP 10 mg/day (group B, 15 patients). RESULTS: Of group A patients, 13/14 (on intention to treat (i-t-t): 86.67%) showed response to budesonide and 10/14 (on i-t-t.: 66.66%) were in remission after 8 weeks of treatment. In group B patients, 10/14 (on i-t-t: 66.66%) showed response to BDP and 8/14 (on i-t-t: 53.33%) were in remission after 8 weeks of treatment (p<0.001). Budesonide was also faster in the time to obtain symptomatic remission (p=n.s.) and was better in improving IBDQL (p<0.05). Regarding side effects, two group A patients (6.66%) and three group B patients (10%) experienced mild-to-moderate side effects which were transitory and did not require any specific treatment or stopping the treatment. CONCLUSIONS: BDP seems to be less effective than budesonide in treating CD, probably due to better the pharmacokinetic properties of budesonide.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Beclomethasone/therapeutic use , Budesonide/therapeutic use , Crohn Disease/drug therapy , Adolescent , Adult , Aged , Beclomethasone/adverse effects , Budesonide/adverse effects , Female , Humans , Male , Middle Aged
20.
J Clin Gastroenterol ; 40(4): 306-11, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16633102

ABSTRACT

GOAL: This study assesses the epithelial cell proliferation in different degrees of diverticular disease and compares this with two different control groups. BACKGROUND: Hyperproliferation of the colonic mucosa has been recently described in diverticular disease (DD), but it is unknown whether this finding is present in every degree of DD. PATIENTS AND METHODS: Thirty consecutive patients with a new endoscopic diagnosis of DD (10 with asymptomatic diverticulosis, 10 with symptomatic uncomplicated DD, and 10 with acute uncomplicated diverticulitis) were enrolled. Ten matched healthy people and 10 patients with ulcerative colitis (UC) (5 with UC in remission and 5 with active UC) were enrolled as control groups. The Ki-67 antigen index of the whole crypt and the upper third was separately evaluated. RESULTS: Ki-67 index of the whole crypt and the upper third of the crypt was significantly higher in all degrees of DD compared with the healthy control group. In particular, asymptomatic diverticulosis showed a threefold higher Ki-67 index compared with that of the healthy control group (5.4% and 5.6% vs. 1.6% and 1.8%, respectively, P = 0.005), and similar to that of UC in remission (5.4% and 5.6% vs. 5.9% and 5.8%, respectively, P = not significant). CONCLUSIONS: We found an upward shifting of cellular proliferation of the colonic mucosa in patients with different degrees of DD. In particular, asymptomatic diverticulosis seems to show the same risk for colonic carcinoma as that of UC.


Subject(s)
Diverticulosis, Colonic/pathology , Epithelial Cells/pathology , Intestinal Mucosa/pathology , Cell Proliferation , Colitis, Ulcerative/pathology , Female , Humans , Immunohistochemistry , Ki-67 Antigen , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...